The Supreme Court blocked a Fifth Circuit order that would have reinstated the FDA's in-person dispensing requirement for mifepristone, preserving mail and telehealth access to the drug while Louisiana's lawsuit against the FDA moves forward, according to CBS News. Justices Thomas and Alito dissented; Thomas invoked the 1873 Comstock Act, writing that the drugmakers "are not entitled to a stay of an adverse court order based on lost profits from their criminal enterprise."